Report Detail

Pharma & Healthcare Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2019-2025

  • RnM3811758
  • |
  • 11 October, 2019
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 CLL - Chronic Iymphocytic Ieukemia
      • 1.4.3 FL - Follicular Iymphoma
      • 1.4.4 Other Indications
    • 1.5 Market by Application
      • 1.5.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2019-2025)
      • 1.5.2 hospital
      • 1.5.3 Research Institutes and Research Institutions
      • 1.5.4 Clinic
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size
    • 2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Trends by Regions
      • 2.2.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Regions (2019-2025)
      • 2.2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by by Players
      • 3.1.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by by Players (2014-2019)
      • 3.1.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio (CR5 and HHI)
    • 3.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players Head office and Area Served
    • 3.3 Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Product/Solution/Service
    • 3.4 Date of Enter into Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2014-2019)
    • 4.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2014-2019)
    • 5.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in North America
    • 5.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
    • 5.4 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application

    6 Europe

    • 6.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2014-2019)
    • 6.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in Europe
    • 6.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
    • 6.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application

    7 China

    • 7.1 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2014-2019)
    • 7.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in China
    • 7.3 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
    • 7.4 China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application

    8 Japan

    • 8.1 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2014-2019)
    • 8.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in Japan
    • 8.3 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
    • 8.4 Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2014-2019)
    • 9.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in Southeast Asia
    • 9.3 Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
    • 9.4 Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application

    10 India

    • 10.1 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2014-2019)
    • 10.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in India
    • 10.3 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
    • 10.4 India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2014-2019)
    • 11.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players in Central & South America
    • 11.3 Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
    • 11.4 Central & South America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application

    12 International Players Profiles

    • 12.1 Bayer AG
      • 12.1.1 Bayer AG Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
      • 12.1.4 Bayer AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2014-2019))
      • 12.1.5 Bayer AG Recent Development
    • 12.2 Gilead Sciences Inc.
      • 12.2.1 Gilead Sciences Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
      • 12.2.4 Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2014-2019)
      • 12.2.5 Gilead Sciences Inc. Recent Development
    • 12.3 Novartis AG
      • 12.3.1 Novartis AG Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
      • 12.3.4 Novartis AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2014-2019)
      • 12.3.5 Novartis AG Recent Development
    • 12.4 TG Therapeutics Inc.
      • 12.4.1 TG Therapeutics Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
      • 12.4.4 TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2014-2019)
      • 12.4.5 TG Therapeutics Inc. Recent Development
    • 12.5 Verastem Inc.
      • 12.5.1 Verastem Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
      • 12.5.4 Verastem Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2014-2019)
      • 12.5.5 Verastem Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Phosphoinositide 3-Kinase (PI3K) Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Phosphoinositide 3-Kinase (PI3K) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Bayer AG
      Gilead Sciences Inc.
      Novartis AG
      TG Therapeutics Inc.
      Verastem Inc.
      ...

      Market segment by Type, the product can be split into
      CLL - Chronic Iymphocytic Ieukemia
      FL - Follicular Iymphoma
      Other Indications

      Market segment by Application, split into
      hospital
      Research Institutes and Research Institutions
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Phosphoinositide 3-Kinase (PI3K) Inhibitors status, future forecast, growth opportunity, key market and key players.
      To present the Phosphoinositide 3-Kinase (PI3K) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Phosphoinositide 3-Kinase (PI3K) Inhibitors are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Phosphoinositide 3-Kinase (PI3K) Inhibitors. Industry analysis & Market Report on Phosphoinositide 3-Kinase (PI3K) Inhibitors is a syndicated market report, published as Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Phosphoinositide 3-Kinase (PI3K) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,129.98
      4,694.98
      6,259.97
      3,536.79
      5,305.18
      7,073.57
      422,167.20
      633,250.80
      844,334.40
      276,980.73
      415,471.10
      553,961.46
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report